Body-surface area-based chemotherapy dosing: appropriate in the 21st century? - PubMed (original) (raw)
Comment
. 2012 Nov 1;30(31):3896-7.
doi: 10.1200/JCO.2012.44.2863. Epub 2012 Sep 10.
- PMID: 22965963
- DOI: 10.1200/JCO.2012.44.2863
Comment
Body-surface area-based chemotherapy dosing: appropriate in the 21st century?
Jan H Beumer et al. J Clin Oncol. 2012.
No abstract available
Comment on
- Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH; American Society of Clinical Oncology. Griggs JJ, et al. J Clin Oncol. 2012 May 1;30(13):1553-61. doi: 10.1200/JCO.2011.39.9436. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473167 Review.
Similar articles
- Clarifying the American Society of Clinical Oncology practice guideline for chemotherapy dosing for obese adults.
Chin PK, Vella-Brincat JW, Begg EJ. Chin PK, et al. J Clin Oncol. 2012 Nov 1;30(31):3897; author reply 3898-9. doi: 10.1200/JCO.2012.44.1626. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965956 No abstract available. - American Society of Clinical Oncology guideline on weight-based dosing and its impact on trial design.
Chambers P, Daniels S, Thompson LC, Stephens R. Chambers P, et al. J Clin Oncol. 2012 Nov 1;30(31):3897-8; author reply 3898-9. doi: 10.1200/JCO.2012.44.4125. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965968 No abstract available. - Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH; American Society of Clinical Oncology. Griggs JJ, et al. J Clin Oncol. 2012 May 1;30(13):1553-61. doi: 10.1200/JCO.2011.39.9436. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473167 Review. - Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T, Mochinaga S, Kimura S, Aragane N, Yakabe T, Morita S, Okudaira K, Fujito H. Miyahara T, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):175-82. doi: 10.1007/s00280-012-1994-8. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064956 - Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.
Lucas CJ, Martin JH. Lucas CJ, et al. J Clin Pharmacol. 2017 Oct;57 Suppl 10:S78-S98. doi: 10.1002/jcph.937. J Clin Pharmacol. 2017. PMID: 28921641 Review.
Cited by
- Predicting drug delivery efficiency into tumor tissues through molecular simulation of transport in complex vascular networks.
Troendle EP, Khan A, Searson PC, Ulmschneider MB. Troendle EP, et al. J Control Release. 2018 Dec 28;292:221-234. doi: 10.1016/j.jconrel.2018.11.010. Epub 2018 Nov 8. J Control Release. 2018. PMID: 30415016 Free PMC article. - Therapeutic drug monitoring of 5-fluorouracil.
Lee JJ, Beumer JH, Chu E. Lee JJ, et al. Cancer Chemother Pharmacol. 2016 Sep;78(3):447-64. doi: 10.1007/s00280-016-3054-2. Epub 2016 May 23. Cancer Chemother Pharmacol. 2016. PMID: 27217046 Free PMC article. Review. - GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer.
McMahon BA, Rosner MH. McMahon BA, et al. Kidney360. 2020 Jan 13;1(2):141-150. doi: 10.34067/KID.0000952019. eCollection 2020 Feb 27. Kidney360. 2020. PMID: 35372903 Free PMC article. Review. - Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.
Gupta N, Hanley MJ, Diderichsen PM, Yang H, Ke A, Teng Z, Labotka R, Berg D, Patel C, Liu G, van de Velde H, Venkatakrishnan K. Gupta N, et al. Clin Pharmacol Ther. 2019 Feb;105(2):376-387. doi: 10.1002/cpt.1047. Epub 2018 Mar 23. Clin Pharmacol Ther. 2019. PMID: 29446068 Free PMC article. Review. - Computer tomography-based body surface area evaluation for drug dosage: Quantitative radiology versus anthropomorphic evaluation.
Iannessi A, Beaumont H, Hebert C, Dittlot C, Falewee MN. Iannessi A, et al. PLoS One. 2018 Feb 14;13(2):e0192124. doi: 10.1371/journal.pone.0192124. eCollection 2018. PLoS One. 2018. PMID: 29444120 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical